A network meta-analysis of second-line immune checkpoint inhibitors and docetaxel for advanced non-small cell lung cancer: An economic evaluation from China
Precision Medication · 2026-06 · 3 (2) · 100092
DOI: 10.1016/j.prmedi.2026.100092 ↗Kurz gefasst
Netzwerk-Metaanalyse in der Zeitschrift Precision Medication, 2026-06. Verfasst von Yunfeng Zhao und 6 weiteren Autor:innen. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Zhao, Y., Meng, F., Shi, F., Zhao, L., Zhang, Y., Liu, S., & Tang, J. (2026). A network meta-analysis of second-line immune checkpoint inhibitors and docetaxel for advanced non-small cell lung cancer: An economic evaluation from China. Precision Medication, 3(2), 100092. https://doi.org/10.1016/j.prmedi.2026.100092
Vancouver
Zhao Y, Meng F, Shi F, Zhao L, Zhang Y, Liu S, et al. A network meta-analysis of second-line immune checkpoint inhibitors and docetaxel for advanced non-small cell lung cancer: An economic evaluation from China. Precision Medication. 2026;3(2):100092. doi:10.1016/j.prmedi.2026.100092
BibTeX
@article{Zhao2026,
author = {Zhao, Yunfeng and Meng, Fanyu and Shi, Fenghao and Zhao, Linbo and Zhang, Yi and Liu, Shuang and Tang, Jianhua},
title = {A network meta-analysis of second-line immune checkpoint inhibitors and docetaxel for advanced non-small cell lung cancer: An economic evaluation from China},
journal = {Precision Medication},
year = {2026},
volume = {3},
number = {2},
pages = {100092},
doi = {10.1016/j.prmedi.2026.100092}
}
EUVIMED